Target intelligence / Profile preview

Hemozoin (β-hematin) (Hz)

Target
Hz
Molecular classification
Biomineral, Metabolic byproduct, Other
01

Overview

Hemozoin, also known as the malaria pigment, is a biocrystal synthesized by Plasmodium parasites during their intraerythrocytic life cycle stage (PubMed: 11591450). As the parasite digests host hemoglobin within its acidic food vacuole to obtain essential amino acids, it releases large quantities of free heme (ferriprotoporphyrin IX), which is highly toxic due to its ability to generate reactive oxygen species and disrupt cellular membranes (Nature: 10.1038/ncomms14401). To survive, the parasite detoxifies this heme by polymerizing it into insoluble, chemically inert hemozoin crystals (PNAS: 10.1073/pnas.0404934101). This biomineralization process is a critical survival mechanism and serves as a major therapeutic target for several classes of antimalarial drugs, most notably the quinolines (Science: 10.1126/science.255.5045.717). Drugs like chloroquine interfere with this process by binding to heme or the crystal surface, preventing further polymerization and causing the buildup of toxic heme-drug complexes that ultimately lead to parasite death (Biochemistry: 10.1021/bi00014a028).

Other names
Malaria pigmentFerriprotoporphyrin IX polymerBeta-hematinHeme crystalHeme polymer
02

Mechanism of action

Inhibition of heme biocrystallization into hemozoin, leading to the accumulation of toxic free ferriprotoporphyrin IX which causes oxidative stress and membrane damage within the parasite food vacuole (PubMed: 15566334).

03

Biological functions

Heme detoxificationHemoglobin catabolismIron sequestrationOther
04

Disease associations

Infection
05

Safety considerations

Drug resistance mediated by mutations in the Plasmodium falciparum chloroquine resistance transporter (PfCRT) (Nature: 10.1038/35036581)Retinal toxicity associated with long-term quinoline useCardiovascular effects including QT prolongationNeurotoxicity
06

Interacting drugs

Chloroquine

7 more in the full profile.

07

Biomarkers

Hemozoin levelsParasitemiaIntraerythrocytic developmental stage

Beyond the preview

Go deeper on Hemozoin (β-hematin) (Hz).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemozoin (β-hematin) (Hz).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call